These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2331050

  • 1. AgNORs in benign, dysplastic, and malignant melanocytic skin lesions.
    Howat AJ, Wright AL, Cotton DW, Reeve S.
    Am J Dermatopathol; 1990 Apr; 12(2):156-61. PubMed ID: 2331050
    [Abstract] [Full Text] [Related]

  • 2. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT, Orrell JM, Grant A.
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [Abstract] [Full Text] [Related]

  • 3. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A, Ghosh RN, Sarkar R, Laha RN, Ghosh TK, Mukherjee C.
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [Abstract] [Full Text] [Related]

  • 4. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM, Evans AT, Grant A.
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [Abstract] [Full Text] [Related]

  • 5. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
    Di Gregorio C, Losi L, Annessi G, Botticelli A.
    Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
    [Abstract] [Full Text] [Related]

  • 6. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R, Raghuveer CV, Jacob DL.
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [Abstract] [Full Text] [Related]

  • 7. Distinguishing benign and malignant melanocytic lesions with the AgNOR method.
    Friedman RJ, Grin CM, Heilman E, Weiser J, Gottlieb GJ, Waldo E, Rigel DS, Kopf AW.
    Dermatol Clin; 1991 Oct; 9(4):689-93. PubMed ID: 1934643
    [Abstract] [Full Text] [Related]

  • 8. AGNORS in skin lesions of cutaneous malignant lymphomas and pseudolymphomas.
    Qiu BS, Xu LZ, Kong JC, Chen HL, Tao LD.
    Chin Med J (Engl); 1992 Jan; 105(1):30-3. PubMed ID: 1576867
    [Abstract] [Full Text] [Related]

  • 9. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R, Armas-Padrón JR, Rios-Martín JJ, López-Garrido J, Gómez-Pascual A, Galera-Davidson H.
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of nucleolar organizer regions (NORS) in malignant melanoma.
    Ronan SG, Farolan MJ, McDonald A, Manaligod JR, Das Gupta TK.
    J Cutan Pathol; 1994 Dec; 21(6):494-9. PubMed ID: 7699115
    [Abstract] [Full Text] [Related]

  • 11. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A, Chiusa L, Margaria E.
    Cancer Detect Prev; 1995 Dec; 19(3):282-91. PubMed ID: 7750118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. AgNOR area measurements differentiate benign and malignant melanocytic lesions more accurately than simple counting.
    Gonzalez AP, Kumar D, Sánchez RL.
    Am J Dermatopathol; 1994 Aug; 16(4):372-6. PubMed ID: 7526724
    [Abstract] [Full Text] [Related]

  • 15. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor?
    Deuble K, McCartney A.
    Eye (Lond); 1990 Aug; 4 ( Pt 5)():743-50. PubMed ID: 1704315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
    Rebora A.
    Dermatology; 1992 Aug; 185(3):166-8. PubMed ID: 1446080
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
    Fogt F, Vortmeyer AO, Tahan SR.
    Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.